Levetiracetam Injection
Product Images NDC 36000-356

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 36000-356). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Bag-10mg-per-ml (Bag 10mg Per mL)

Bag-10mg-per-ml (Bag 10mg Per mL)
Levetiracetam injection label for 1000 mg per 100 mL (10 mg/mL) in 0.75% sodium chloride, intended for intravenous infusion. The label states a 100 mL volume with detailed composition including levetiracetam and buffer components. Manufactured by Baxter Healthcare Corporation, Deerfield, IL, made in Ireland. Includes storage instructions, usage warnings, barcode, and lot/expiration placeholders.*
FDA Label Image

Bag-15mg-per-ml (Bag 15mg Per mL)

Bag-15mg-per-ml (Bag 15mg Per mL)
Label for Levetiracetam Injection 15 mg/mL (1500 mg/100 mL) in 0.54% Sodium Chloride for intravenous infusion. The 100 mL single-dose vial is manufactured by Baxter Healthcare Corporation, Deerfield, IL, USA, and made in Ireland. Storage, usage, and caution instructions appear, including infusion time and container compatibility.*
FDA Label Image

Bag-5mg-per-ml (Bag 5mg Per mL)

Bag-5mg-per-ml (Bag 5mg Per mL)
Label for Levetiracetam Injection in 0.82% Sodium Chloride, 500 mg/100 mL (5 mg/mL) for intravenous infusion. The 100 mL single-dose bag label provides usage instructions, cautions, recommended storage (20° to 25°C), and manufacturer details for Baxter Healthcare Corporation. Contains barcode and regulatory markings.*
FDA Label Image

Description (Description)

Description (Description)
Chemical structure of levetiracetam. The diagram shows the molecular arrangement of levetiracetam, highlighting the lactam and amide functional groups along with its chiral center.*
FDA Label Image

Figure-01 (Figure 01)

Figure-01 (Figure 01)
A bar graph showing the percentage of patients in three groups: Placebo, Levetiracetam 1000 mg/day, and Levetiracetam 3000 mg/day. The percentage of patients is highest for Levetiracetam 3000 mg/day at 39.6%, followed by Levetiracetam 1000 mg/day at 37.1%, and lowest for Placebo at 7.4%. Asterisks indicate statistical significance versus placebo.*
FDA Label Image

Figure-02 (Figure 02)

Figure-02 (Figure 02)
A bar chart comparing the percentage of patients across three groups: Placebo, Levetiracetam 1000 mg/day, and Levetiracetam 2000 mg/day. The y-axis represents the percentage of patients, ranging from 0% to 45%. Percentages shown are 6.3% for Placebo, 20.8% for Levetiracetam 1000 mg/day, and 35.2% for Levetiracetam 2000 mg/day, with asterisks marking statistical significance versus placebo.*
FDA Label Image

Figure-03 (Figure 03)

Figure-03 (Figure 03)
A bar chart comparing the percentage of patients experiencing a given outcome in two groups: Placebo (N=104) at 14.4% and Levetiracetam 3000 mg/day (N=180) at 39.4%, with an asterisk indicating statistical significance versus placebo. The y-axis represents percentage of patients from 0% to 45%.*
FDA Label Image

Figure-04 (Figure 04)

Figure-04 (Figure 04)
A vertical bar chart comparing the percentage of patients in placebo and levetiracetam groups. The placebo group (N=84) shows 45.2% of patients, while the levetiracetam group (N=79) shows 72.2%, marked as statistically significant versus placebo.*
FDA Label Image

Overwrap-10mg-per-ml (Overwrap 10mg Per mL)

Overwrap-10mg-per-ml (Overwrap 10mg Per mL)
Levetiracetam 1000 mg/100 mL (10 mg/mL) intravenous injection in 0.75% sodium chloride, supplied as a single-dose 100 mL bag. Label indicates use for intravenous infusion only with storage instructions, cautions, and manufacturer details for Baxter Healthcare Corporation.*
FDA Label Image

Overwrap-15mg-per-ml (Overwrap 15mg Per mL)

Overwrap-15mg-per-ml (Overwrap 15mg Per mL)
Label for Levetiracetam Injection 1500 mg/100 mL (15 mg/mL) in 0.54% Sodium Chloride for intravenous infusion. The product is a single-dose 100 mL bag manufactured for Baxter Healthcare Corporation. The label includes preparation and storage instructions, cautions, and manufacturing details including made in Ireland.*
FDA Label Image

Overwrap-5mg-per-ml (Overwrap 5mg Per mL)

Overwrap-5mg-per-ml (Overwrap 5mg Per mL)
Levetiracetam injection in 0.82% Sodium Chloride for intravenous infusion, strength 500 mg/100 mL (5 mg/mL), provided as a single-dose 100 mL bag. The label includes instructions for use, storage recommendations, and cautions. Manufactured for Baxter Healthcare Corporation, made in Ireland.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.